News provided by Ivim Health Mar 12, 2026, 09:15 ET Two peer-reviewed studies published in Obesity Pillars report that Ivim Health patients receiving GLP-1 therapy within a comprehensive care protocol achieved up to 26.54% average weight loss in real-world observational cohorts
Despite decades of research, until recently, 5-8% short-term weight reductions were considered the gold standard in pharmacological stand-alone weight loss interventions
Sources and Further Reading NHS, how to use medicines safely: MHRA, reporting side effects (Yellow Card): NICE, tirzepatide for managing overweight and obesity (TA1026):
Understanding your options and what to expect Delivery timing and how the process works General questions before you decide What Is Ozempic and How Does It Work
Found is also insurance-aware, but the user experience is more intake-first